Skip to main content
Advertisement
  • Loading metrics

PLoS Genetics Issue Image | Vol. 4(8) August 2008

  • Article
  • Metrics
  • Comments
  • Media Coverage

Using yeast to understand the side effects of psychoactive drugs.

Neuropsychiatric disorders such as depression and psychosis affect 1/4 of all individuals during their lifetime, and despite efforts to improve the selectivity of psychoactive drugs, all are associated with side effects. Using a genome-wide chemogenomic assay, the authors found that these medications perturbed many evolutionarily conserved genes and cellular pathways (see Ericson et al., doi:10.1371/journal.pgen.1000151).

Image Credit: Trine Giaever

thumbnail
Using yeast to understand the side effects of psychoactive drugs.

Neuropsychiatric disorders such as depression and psychosis affect 1/4 of all individuals during their lifetime, and despite efforts to improve the selectivity of psychoactive drugs, all are associated with side effects. Using a genome-wide chemogenomic assay, the authors found that these medications perturbed many evolutionarily conserved genes and cellular pathways (see Ericson et al., doi:10.1371/journal.pgen.1000151).

Image Credit: Trine Giaever

https://doi.org/10.1371/image.pgen.v04.i08.g001